Surgical management of cutaneous malignant melanoma. Review;Mise au point sur la prise en charge chirurgicale du mélanome malin cutané. Revue de la littérature

Annales de Chirurgie Plastique Esthetique

Volumn 52, Issue 1, 2007, Pages 1-13

  Lavie, A ^a   Desouches, C ^a   Casanova, D ^b   Bardot, J ^a   Grob, J J ^c   Legre R ^a   Magalon, G ^a  

^a HÔPITAL DE LA CONCEPTION   (France)

^b HÔPITAL NORD   (France)

^c HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

Guideline; Melanoma; Review; Surgery

Indexed keywords

HUMAN; MELANOMA; PATHOLOGY; REVIEW; SENTINEL LYMPH NODE BIOPSY; SKIN TUMOR; TUMOR RECURRENCE;

HUMANS; MELANOMA; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 33846844746     PISSN: 02941260     EISSN: 1768319X     Source Type: Journal    
DOI: 10.1016/j.anplas.2006.08.004     Document Type: Short Survey

References (124)

1. Grob J.J., and Richard M.A. Epidemiology and prevention of melanoma. Rev. Prat. 54 11 (2004) 1181-1186
2. Grange F. Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann. Dermatol. Venereol. 132 12 Pt 1 (2005) 975-982
3. Negrier S., Saiag P., Guillot B., Verola O., Avril M.F., Bailly C., et al. Guidelines for clinical practice: Standards, Options and Recommendations 2005 for the management of adult patients exhibiting an MO cutaneous melanoma, full report. Ann. Dermatol. Venereol. 132 12 Pt 2 (2005) 10S3-10S85
4. Austin J.R., Byers R.M., Brown W.D., and Wolf P. Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck 18 2 (1996) 107-117
5. Witheiler D.D., and Cockerell C.J. Sensitivity of diagnosis of malignant melanoma: a clinicopathologic study with a critical assessment of biopsy techniques. Exp. Dermatol. 1 4 (1992) 170-175
6. Macy-Roberts E., and Ackerman A.B. A critique of techniques for biopsy of clinically suspected malignant melanomas. Am. J. Dermatopathol. 4 5 (1982) 391-398
7. Agarwal-Antal N., Bowen G.M., and Gerwels J.W. Histologic evaluation of lentigo maligna with permanent sections: implications regarding current guidelines. J. Am. Acad. Dermatol. 47 5 (2002) 743-748
8. Somach S.C., Taira J.W., Pitha J.V., and Everett M.A. Pigmented lesions in actinically damaged skin. Histopathologic comparison of biopsy and excisional specimens. Arch. Dermatol. 132 11 (1996) 1297-1302
9. Whitaker D.K., and Sinclair W. Guideline on the management of melanoma. S. Afr. Med. J. 94 8 Pt 3 (2004) 699-707 (quiz 708)
10. Veronesi U., and Cascinelli N. Surgical treatment of malignant melanoma of the skin. World J. Surg. 3 3 (1979) 279-288
11. Weitz J., and Herfarth C. Surgical strategies and minimal residual disease detection. Semin. Surg. Oncol. 20 4 (2001) 329-333
12. Pujol H., and Banzet P. Les mélanomes malins cutanés et leur traitement. Monographies de l'association française de chirurgie 1 (1982) 41-45
13. Negrier S., Fervers B., Bailly C., Beckendorf V., Cupissol D., Dore J.F., et al. Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer. Bull. Cancer 87 2 (2000) 173-182
14. Scolyer R.A., Thompson J.F., Stretch J.R., Sharma R., and McCarthy S.W. Pathology of melanocytic lesions: new, controversial, and clinically important issues. J. Surg. Oncol. 86 4 (2004) 200-211
15. Eigentler T.K., Radny P., Kamin A., Weide B., Caroli U.M., and Garbe C. Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma. J. Dtsch Dermatol. Ges. 3 8 (2005) 592-598
16. Testori A., and Mozzillo N. Surgical techniques of melanoma and sentinel node biopsy. Semin. Oncol. 29 4 (2002) 328-335
17. Karimipour D.J., Schwartz J.L., Wang T.S., Bichakjian C.K., Orringer J.S., King A.L., et al. Microstaging accuracy after subtotal incisional biopsy of cutaneous melanoma. J. Am. Acad. Dermatol. 52 5 (2005) 798-802
18. Shapiro R.L. Surgical approaches to malignant melanoma. Practical guidelines. Dermatol. Clin. 20 4 (2002) 681-699 (ix)
19. Eldh J. Excisional biopsy and delayed wide excision versus primary wide excision of malignant melanoma. Scand. J. Plast. Reconstr. Surg. 13 2 (1979) 341-345
20. Lederman J.S., and Sober A.J. Does wide excision as the initial diagnostic procedure improve prognosis in patients with cutaneous melanoma?. J. Dermatol. Surg. Oncol. 12 7 (1986) 697-699
21. Hueston J.T. Integumentectomy for malignant melanoma of the limbs. Aust. N. Z. J. Surg. 40 2 (1970) 114-118
22. Kenady D.E., Brown B.W., and McBride C.M. Excision of underlying fascia with a primary malignant melanoma: effect on recurrence and survival rates. Surgery 92 4 (1982) 615-618
23. Seigler H.F. Investigative studies in the diagnosis and treatment of melanoma. Invest. Radiol. 21 7 (1986) 596-600
24. Pritchard D.J., and Sim F.H. Surgical management of malignant melanoma of the trunk and extremities. Mayo Clin. Proc. 64 7 (1989) 846-851
25. Cade S. Malignant melanoma. Ann. R. Coll. Surg. Engl. 28 (1961) 331-366
26. Bogle M., Kelly P., Shenaq J., Friedman J., and Evans G.R. The role of soft tissue reconstruction after melanoma resection in the head and neck. Head Neck 23 1 (2001) 8-15
27. Eshima I. The role of plastic surgery in the treatment of malignant melanoma. Surg. Clin. North Am. 76 6 (1996) 1331-1342
28. Balch C.M. Excising melanomas: how wide is enough? And how to reconstruct?. J. Surg. Oncol. 44 3 (1990) 135-137
29. Essner R. Surgical treatment of malignant melanoma. Surg. Clin. North Am. 83 1 (2003) 109-156
30. van Aalst J.A., McCurry T., and Wagner J. Reconstructive considerations in the surgical management of melanoma. Surg. Clin. North Am. 83 1 (2003) 187-230
31. Chin B.S., Franco R., Sabin S., Turk J., Erickson A., and Ghosh B.C. Nasal reconstruction for malignant melanoma. J. Surg. Oncol. 67 4 (1998) 265-266
32. Sekido M., Yamamoto Y., Tsutsumida A., Yoshida T., Minakawa H., Nohira K., et al. Reconstructive considerations after resection of malignant melanoma in the head and neck. Scand. J. Plast. Reconstr. Surg. Hand Surg. 39 4 (2005) 222-226
33. Komorowska-Timek E., Gabriel A., Bennett D.C., Miles D., Garberoglio C., Cheng C., et al. Artificial dermis as an alternative for coverage of complex scalp defects following excision of malignant tumors. Plast. Reconstr. Surg. 115 4 (2005) 1010-1017
34. Hudson D.A., Krige J.E., Strover R.M., and King H.S. Malignant melanoma of the external ear. Br. J. Plast. Surg. 43 5 (1990) 608-611
35. Narayan D., and Ariyan S. Surgical considerations in the management of malignant melanoma of the ear. Plast. Reconstr. Surg. 107 1 (2001) 20-24
36. Byers R.M., Smith J.L., Russell N., and Rosenberg V. Malignant melanoma of the external ear. Review of 102 cases. Am. J. Surg. 140 4 (1980) 518-521
37. Pack G.T., Conley J., and Oropeza R. Melanoma of the external ear. Arch. Otolaryngol. 92 2 (1970) 106-113
38. Cole D.J., Mackay G.J., Walker B.F., Wooden W.A., Murray D.R., and Coleman III J.J. Melanoma of the external ear. J. Surg. Oncol. 50 2 (1992) 110-114
39. Jahn V., Breuninger H., Garbe C., and Moehrle M. Melanoma of the ear: prognostic factors and surgical strategies. Br. J. Dermatol. 154 2 (2006) 310-318
40. Wanebo H.J., Cooper P.H., Young D.V., Harpole D.H., and Kaiser D.L. Prognostic factors in head and neck melanoma. Effect of lesion location. Cancer 62 4 (1988) 831-837
41. Ariyan S. Reconstructive surgery in melanoma patients. Surg. Oncol. Clin. N. Am. 5 4 (1996) 785-807
42. Antia N.H., and Buch V.I. Chondrocutaneous advancement flap for the marginal defect of the ear. Plast. Reconstr. Surg. 39 5 (1967) 472-477
43. Stadelmann W.K., McMasters K., Digenis A.G., and Reintgen D.S. Cutaneous melanoma of the head and neck: advances in evaluation and treatment. Plast. Reconstr. Surg. 105 6 (2000) 2105-2126
44. Letourneau A., and Daniel R.K. The superficial musculoaponeurotic system of the nose. Plast. Reconstr. Surg. 82 1 (1988) 48-57
45. Papadopoulos T., Rasiah K., Thompson J.F., Quinn M.J., and Crotty K.A. Melanoma of the nose. Br. J. Surg. 84 7 (1997) 986-989
46. Mohs F.E., Snow S.N., and Larson P.O. Mohs micrographic surgery fixed-tissue technique for melanoma of the nose. J. Dermatol. Surg. Oncol. 16 12 (1990) 1111-1120
47. Converse J.M. Reconstruction of the nose by the scalping flap technique. Surg. Clin. North Am. 39 2 (1959) 335-365
48. Esmaeli B., Wang B., Deavers M., Gillenwater A., Goepfert H., Diaz E., et al. Prognostic factors for survival in malignant melanoma of the eyelid skin. Ophthal. Plast. Reconstr. Surg. 16 4 (2000) 250-257
49. Esmaeli B., Youssef A., Naderi A., Ahmadi M.A., Meyer D.R., and McNab A. Margins of excision for cutaneous melanoma of the eyelid skin: the Collaborative Eyelid Skin Melanoma Group Report. Ophthal. Plast. Reconstr. Surg. 19 2 (2003) 96-101
50. Mustarde J.C. Reconstruction of the eyelid. Minerva Chir. 22 17 (1967) 933-942
51. Mustarde J.C. Major reconstruction of the eyelids: functional and aesthetic considerations. Clin. Plast. Surg. 8 2 (1981) 227-236
52. Papadopoulos T., Thompson J.F., and Quinn M.J. Melanoma of the lip. Aust. N. Z. J. Surg. 66 5 (1996) 327-330
53. Franc C., Braye F., Breton P., and Freidel M. The Abbe-Estlander flap: anatomic basis, surgical technic and indications for lip repair. Rev. Stomatol. Chir. Maxillofac. 97 2 (1996) 92-102
54. Smith L.M., and Osborne R.F. The Karapandzic flap in recurrent melanoma of the lip. Ear Nose Throat. J. 83 10 (2004) 684-698
55. Yih W.Y., and Howerton D.W. A regional approach to reconstruction of the upper lip. J. Oral Maxillofac. Surg. 55 4 (1997) 383-389
56. Williams III E.F., Setzen G., and Mulvaney M.J. Modified Bernard-Burow cheek advancement and cross-lip flap for total lip reconstruction. Arch. Otolaryngol. Head Neck Surg. 122 11 (1996) 1253-1258
57. Feibleman C.E., Stoll H., and Maize J.C. Melanomas of the palm, sole, and nailbed: a clinicopathologic study. Cancer 46 11 (1980) 2492-2504
58. Quinn M.J., Thompson J.E., Crotty K., McCarthy W.H., and Coates A.S. Subungual melanoma of the hand. J. Hand Surg. [Am.] 21 3 (1996) 506-511
59. Rigby H.S., and Briggs J.C. Subungual melanoma: a clinico-pathological study of 24 cases. Br. J. Plast. Surg. 45 4 (1992) 275-278
60. Blessing K., Kernohan N.M., and Park K.G. Subungual malignant melanoma: clinicopathological features of 100 cases. Histopathology 19 5 (1991) 425-429
61. O'Leary J.A., Berend K.R., Johnson J.L., Levin L.S., and Seigler H.F. Subungual melanoma. A review of 93 cases with identification of prognostic variables. Clin. Orthop. Relat. Res. 378 (2000) 206-212
62. Bali D., Casanova D., Aharoni C., Mutaftschiev N., Cilirie K., and Legre R. Longitudinal melanic nail bands (melanonychia): report of 22 cases. Chir. Main 21 4 (2002) 225-234
63. Schernberg F., and Ameil M. Local rotational flap of the nail. Handchir. Mikrochir. Plast. Chir. 19 5 (1987) 259-262
64. Finley III R.K., Driscoll D.L., Blumenson L.E., and Karakousis C.P. Subungual melanoma: an eighteen-year review. Surgery 116 1 (1994) 96-100
65. Moehrle M., Metzger S., Schippert W., Garbe C., Rassner G., and Breuninger H. Functional surgery in subungual melanoma. Dermatol. Surg. 29 4 (2003) 366-374
66. Lazar A., Abimelec P., and Dumontier C. Full thickness skin graft for nail unit reconstruction. J. Hand Surg. [Br.] 30 2 (2005) 194-198
67. Park K.G., Blessing K., Kernohan N.M., and The Scottish Melanoma Group. Surgical aspects of subungual malignant melanomas. Ann. Surg. 216 6 (1992) 692-695
68. Heaton K.M., el-Naggar A., Ensign L.G., Ross M.I., and Balch C.M. Surgical management and prognostic factors in patients with subungual melanoma. Ann. Surg. 219 2 (1994) 197-204
69. Quinn M.J., Wikramanayake R., Thompson J.F., and McCarthy W.H. Non-subungual melanomas of the hand. J. Hand Surg. [Br.] 17 4 (1992) 433-436
70. Veronesi U., Adamus J., Bandiera D.C., Brennhovd I.O., Caceres E., Cascinelli N., et al. Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N. Engl. J. Med. 297 12 (1977) 627-630
71. Cascinelli N., Morabito A., Santinami M., MacKie R.M., and Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet 351 9105 (1998) 793-796
72. Balch C.M., and Ross M.I. The importance of lymphatic anatomy in melanoma--a resurgence of clinical significance in an era of sentinel lymph node technology. J. Am. Coll. Surg. 189 2 (1999) 204-206
73. Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch. Surg. 127 4 (1992) 392-399
74. Gershenwald J.E., Thompson W., Mansfield P.F., Lee J.E., Colome M.I., Tseng C.H., et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J. Clin. Oncol. 17 3 (1999) 976-983
75. Puleo C.A., Messina J.L., Riker A.I., Glass L.F., Nelson C., Cruse C.W., et al. Sentinel node biopsy for thin melanomas: which patients should be considered?. Cancer Control 12 4 (2005) 230-235
76. Wong S.L., Brady M.S., Busam K.J., and Coit D.G. Results of sentinel lymph node biopsy in patients with thin melanoma. Ann. Surg. Oncol. 13 3 (2006) 302-309
77. Butter A., Hui T., Chapdelaine J., Beaunoyer M., Flageole H., and Bouchard S. Melanoma in children and the use of sentinel lymph node biopsy. J. Pediatr. Surg. 40 5 (2005) 797-800
78. Morton D.L. Sentinel lymphadenectomy for patients with clinical stage I melanoma. J. Surg. Oncol. 66 4 (1997) 267-269
79. Leong W.L., Ghazarian D.M., and McCready D.R. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity. J. Surg. Oncol. 82 3 (2003) 143-146
80. Trost O., Danino A.M., Kadlub N., Dalac S., Herve C., and Malka G. What about sentinel node practice in early-staged cutaneous melanoma in France in 2003?. Ann. Chir. Plast. Esthet. 50 2 (2005) 99-103
81. Alex J.C., Weaver D.L., Fairbank J.T., Rankin B.S., and Krag D.N. Gamma-probe-guided lymph node localization in malignant melanoma. Surg. Oncol. 2 5 (1993) 303-308
82. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg. Oncol. 2 6 (1993) 335-339 (discussion 340)
83. Leong S.P. Selective sentinel lymph node mapping and dissection for malignant melanoma. Cancer Treat. Res. 111 (2002) 39-64
84. Leong S.P. Sentinel lymph node mapping and selective lymphadenectomy: the standard of care for melanoma. Curr. Treat. Options Oncol. 5 3 (2004) 185-194
85. Marchal F., Rauch P., Olivier P., Leroux A., Geoffrois L., Dolivet G., et al. Use of sentinel lymph node technique in cutaneous melanoma: preliminary experience. Bull. Cancer 91 7-8 (2004) 621-628
86. Uren R.F., Howman-Giles R., Thompson J.F., Shaw H.M., Quinn M.J., O'Brien C.J., et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res. 4 6 (1994) 395-399
87. Stradling B., Aranha G., and Gabram S. Adverse skin lesions after methylene blue injections for sentinel lymph node localization. Am. J. Surg. 184 4 (2002) 350-352
88. Karakousis C.P., Velez A.F., Spellman Jr. J.E., and Scarozza J. The technique of sentinel node biopsy. Eur. J. Surg. Oncol. 22 3 (1996) 271-275
89. Mariani G., Erba P., Manca G., Villa G., Gipponi M., Boni G., et al. Radioguided sentinel lymph node biopsy in patients with malignant cutaneous melanoma: the nuclear medicine contribution. J. Surg. Oncol. 85 3 (2004) 141-151
90. Thompson J.F., and Uren R.F. Lymphatic mapping and sentinel node biopsy for melanoma. Expert Rev. Anticancer Ther. 1 3 (2001) 446-452
91. Stojadinovic A., Allen P.J., Clary B.M., Busam K.J., and Coit D.G. Value of frozen-section analysis of sentinel lymph nodes for primary cutaneous malignant melanoma. Ann. Surg. 235 1 (2002) 92-98
92. Sappey M. Anatomie, physiologie, pathologie des vaisseaux lymphatiques chez l'homme et les vertébrés (1874), Adrien Delahaye, Paris
93. Sumner III W.E., Ross M.I., Mansfield P.F., Lee J.E., Prieto V.G., Schacherer C.W., et al. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 95 2 (2002) 354-360
94. McMasters K.M., Chao C., Wong S.L., Wrightson W.R., Ross M.I., Reintgen D.S., et al. Interval sentinel lymph nodes in melanoma. Arch. Surg. 137 5 (2002) 543-547 (discussion 547-9)
95. Thompson J.F., and Uren R.F. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol. 6 11 (2005) 877-885
96. Wrightson W.R., Wong S.L., Edwards M.J., Chao C., Reintgen D.S., Ross M.I., et al. Complications associated with sentinel lymph node biopsy for melanoma. Ann. Surg. Oncol. 10 6 (2003) 676-680
97. Morton D.L., Thompson J.F., Essner R., Elashoff R., Stern S.L., Nieweg O.E., et al. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann. Surg. 230 4 (1999) 453-463 (discussion 463-5)
98. Wohrl S., Focke M., Hinterhuber G., Stingl G., and Binder M. Near-fatal anaphylaxis to patent blue V. Br. J. Dermatol. 150 5 (2004) 1037-1038
99. Crivellaro M., Senna G., Dama A., Bonadonna P., and Passalacqua G. Anaphylaxis due to patent blue dye during lymphography, with negative skin prick test. J. Investig. Allergol. Clin. Immunol. 13 1 (2003) 71-72
100. Raut C.P., Hunt K.K., Akins J.S., Daley M.D., Ross M.I., Singletary S.E., et al. Incidence of anaphylactoid reactions to isosulfan blue dye during breast carcinoma lymphatic mapping in patients treated with preoperative prophylaxis: results of a surgical prospective clinical practice protocol. Cancer 104 4 (2005) 692-699
101. van der Horst J.C., de Bock M.J., and Klinkenbijl J.H. [Anaphylactic shock after injection of patent blue for sentinel lymph node biopsy]. Ned. Tijdschr. Geneeskd. 145 43 (2001) 2086-2088
102. Drepper H., Kohler C.O., Bastian B., Breuninger H., Brocker E.B., Gohl J., et al. Benefit of elective lymph node dissection in subgroups of melanoma patients. Results of a multicenter study of 3616 patients. Cancer 72 3 (1993) 741-749
103. Reintgen D.S., Cox E.B., McCarty Jr. K.S., Vollmer R.T., and Seigler H.F. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma. Ann. Surg. 198 3 (1983) 379-385
104. Lens M.B., Dawes M., Goodacre T., and Newton-Bishop J.A. Elective lymph node dissection in patients with melanoma: systematic review and meta-analysis of randomized controlled trials. Arch. Surg. 137 4 (2002) 458-461
105. Karakousis C.P., Balch C.M., Urist M.M., Ross M.M., Smith T.J., and Bartolucci A.A. Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial. Ann. Surg. Oncol. 3 5 (1996) 446-452
106. Hayes A.J., Clark M.A., Harries M., and Thomas J.M. Management of in-transit metastases from cutaneous malignant melanoma. Br. J. Surg. 91 6 (2004) 673-682
107. Olsen G. Some views on the treatment of melanomas of the skin. Arch. Chir. Neerl. 22 2 (1970) 79-90
108. Brown C.D., and Zitelli J.A. The prognosis and treatment of true local cutaneous recurrent malignant melanoma. Dermatol. Surg. 21 4 (1995) 285-290
109. Hafstrom L., Rudenstam C.M., Blomquist E., Ingvar C., Jonsson P.E., Lagerlof B., et al., Swedish Melanoma Study Group. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. J. Clin. Oncol. 9 12 (1991) 2091-2094
110. Wong J.H., Cagle L.A., Kopald K.H., Swisher S.G., and Morton D.L. Natural history and selective management of in transit melanoma. J. Surg. Oncol. 44 3 (1990) 146-150
111. Morris K.T., Marquez C.M., Holland J.M., and Vetto J.T. Prevention of local recurrence after surgical debulking of nodal and subcutaneous melanoma deposits by hypofractionated radiation. Ann. Surg. Oncol. 7 9 (2000) 680-684
112. Spanknebel K., and Kaufman H.L. Surgical treatment of stage IV melanoma. Clin. Dermatol. 22 3 (2004) 240-250
113. Singletary S.E., Tucker S.L., and Boddie Jr. A.W. Multivariate analysis of prognostic factors in regional cutaneous metastases of extremity melanoma. Cancer 61 7 (1988) 1437-1440
114. Buzaid A.C., Ross M.I., Balch C.M., Soong S., McCarthy W.H., Tinoco L., et al. Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system. J. Clin. Oncol. 15 3 (1997) 1039-1051
115. Kelly J.W., Sagebiel R.W., Calderon W., Murillo L., Dakin R.L., and Blois M.S. The frequency of local recurrence and microsatellites as a guide to reexcision margins for cutaneous malignant melanoma. Ann. Surg. 200 6 (1984) 759-763
116. Essner R., Lee J.H., Wanek L.A., Itakura H., and Morton D.L. Contemporary surgical treatment of advanced-stage melanoma. Arch. Surg. 139 9 (2004) 961-966 (discussion 966-7)
117. Jaques D.P., Coit D.G., and Brennan M.F. Major amputation for advanced malignant melanoma. Surg. Gynecol. Obstet. 169 1 (1989) 1-6
118. Merimsky O., Kollender Y., Inbar M., Lev-Chelouche D., Gutman M., Issakov J., et al. Is forequarter amputation justified for palliation of intractable cancer symptoms?. Oncology 60 1 (2001) 55-59
119. Hill S., and Thomas J.M. Use of the carbon dioxide laser to manage cutaneous metastases from malignant melanoma. Br. J. Surg. 83 4 (1996) 509-512
120. Waters R.A., Clement R.M., and Thomas J.M. Carbon dioxide laser ablation of cutaneous metastases from malignant melanoma. Br. J. Surg. 78 4 (1991) 493-494
121. Stehlin Jr. J.S. Hyperthermic perfusion with chemotherapy for cancers of the extremities. Surg. Gynecol. Obstet. 129 2 (1969) 305-308
122. Skene A.I., Bulman A.S., Williams T.R., Thomas J.M., and Westbury G. Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. Br. J. Surg. 77 7 (1990) 765-767
123. Grunhagen D.J., de Wilt J.H., van Geel A.N., and Eggermont A.M. Isolated limb perfusion for melanoma patients-a review of its indications and the role of tumour necrosis factor-alpha. Eur J. Surg. Oncol. (2006)
124. Hill S., and Thomas J.M. Low-dose tumour necrosis factor-alpha (TNF-alpha) and melphalan in hyperthermic isolated limb perfusion. Results from a pilot study performed in the United Kingdom. Melanoma Res. 4 Suppl 1 (1994) 31-34